Stay updated on CMP-001 Combo With Nivolumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record for CMP-001 combined with nivolumab in patients with stage IIIB/C/D melanoma is displayed, including its completed status, treatment plan, eligibility criteria, outcomes, and published research.
    Difference
    59%
    Check dated 2026-11-09T12:35:52.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2. The page content continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T11:58:44.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    An NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content, with a link to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T11:12:30.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site revision shown in the footer changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T12:15:31.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:32:17.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now serves a 403 error page, replacing the previous study record content and navigation with a standard error screen. The page content is effectively inaccessible to users.
    Difference
    20%
    Check dated 2026-09-21T22:25:33.000Z thumbnail image

Stay in the know with updates to CMP-001 Combo With Nivolumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.